Extended Lymphadenectomy Does Not Improve DFS or OS Among Patients with Localised Muscle Invasive Bladder Cancer By Ogkologos - November 4, 2024 1722 0 Facebook Twitter Google+ Pinterest WhatsApp Findings from the SWOG S1011 study Source RELATED ARTICLESMORE FROM AUTHOR ESMO’s Special Consultative Status with United Nations Economic and Social Council (UN ECOSOC) Confirmed Until 2028 EMA Recommends Extension of Indications for Selumetinib ESMO Calls for Urgent Changes to the in Vitro Diagnostic Medical Devices Regulation (IVDR) in Order to Safeguard Cancer Research in Europe MOST POPULAR Woman Uses Passion For Crocheting To Help Cancer Patients, The Homeless... February 9, 2022 A PET-based, pCR-adapted Chemotherapy De-escalation Strategy Associated with an Excellent 3-year... April 5, 2024 Researchers Create Modified Antibodies to Target RAS and p53 in Cancer April 2, 2021 Dual-Function Virus Engineered to Kill Tumor Cells and Support Immune Cells October 15, 2019 Load more HOT NEWS Post-Mastectomy Boutique Set to Close After 12 Years, As Owner Has... Can Eating Soy Cause Breast Cancer? Νέος βιοδείκτης για τις γυναίκες πριν την εμμηνόπαυση Whole-Genome Sequencing Provides Rapid and Accurate Genomic Profiling in Patients with...
